OUR ACTIVITIES
The Department of Clinical Pharmacy teaches the following courses in Lithuanian and English to the students of the Faculty of Pharmacy: Biopharmaceuticals (Year III), Pharmaceutical Biotechnology (Year IV), Clinical Pharmacy within module Disease Management (Year IV), Biological Pharmaceuticals under module Development of Pharmaceutical Products and elective course Clinical Studies of Pharmaceuticals (Year V). Courses taught under the KTU-LSMU joint Master’s study programme “Medicinal Chemistry”: Drug Development and Scientific Research Project 1 (Year I), Scientific Research Project 2 (Year II).
The Department also conducts doctoral studies. At present, 3 doctoral students study at the Department.
Mandatory subjects
Biopharmaceuticals (Year III), Pharmaceutical Biotechnology (Year IV), Clinical Pharmacy within the module Disease Management (Year IV), Biological Pharmaceuticals, Drug Development, and Scientific Research Practice under the module Development of Pharmaceutical Products (Year V).
Elective subjects
Elective subjects taught under the KTU-LSMU joint Master’s study programme “Medicinal Chemistry”: Scientific Research Project 1 (Year I), Scientific Research Project 2 (Year II). Elective course Clinical Studies of Pharmaceuticals (Year V) under the study programme “Pharmacy”.
Clinical pharmaceutical aspects of application of medicinal products. Biopharmaceutics of drugs: the effect of pharmaceutical and physiological factors on the bioavailability of medicinal substances.
- Project “Separation of anticancer fractions from willow-herb and their molecular and biological analysis” by research groups of the Research Council of Lithuania, No. MIP-084/2012. Implementation period: 2012–2014. Project funded by the Lithuanian State Science and Studies Foundation. Implementation period: 2012–2014.
- Infrastructure construction and renovation for biotechnology and biopharmaceutical specialist education and R&D activities (BIOTEFA-C/D). Implementation period: 2012–2014.
- Project “Selection of buckwheat varieties and growing conditions, development of technology to increase the content of functional components” of the National Research Programme “Healthy and Safe Food” of the Research Council of Lithuania. Project funded by the Lithuanian State Science and Studies Foundation. Implementation period: 2014–2015.
- Commercialisation of skin care cosmetic line “Mama ir kūdikis” (Derma). UAB Cordata LT (KTU-LSMU). The Agency for Science, Innovation and Technology (MITA). Implementation period: 2015–2016.
- “Production and Analysis of Functional Nano, Micro Textile Materials with Biological Active Compounds” (TEXTILBAC) (KTU-LSMU). Project implementation period: 2014–2016.
- Project “Study of propolis flavonoids permeation through the skin ex vivo”. Project implementation period: 2017–2018.
- Project “Study of applicability of circular dichroism spectroscopy to the assessment of interaction between albumin and antifungal agents”. Research project funded under measure 09.3.3-LMT-K-712 “Development of Scientific Competences of Scientists, other Researchers and Students through Practical Research Activities” of the European Social Fund.
- Project “Strategy on the drug delivery 3D printed matrices for the development of custom human implants” (No. S-M-ERA.NET-18-2). Project implementation period: 2018–2020.
- Project “Development and assessment of the high-concentration water-based propolis solution technology”. Project No. 01.2.1-MITA-T-851. Source of funding/programme: 01.2.1-MITA-T-851 Innovation Vouchers. Implementation period: 2020–2021.
- Project “Applied research programmes dedicated to the beekeeping and beekeeping products No. BITE-KK-20-1-00532-PR001 (S20083)”. Source of funding/programme: the European Agricultural Guarantee Fund 2021. Implementation period: 2021.
The Department of Clinical Pharmacy collaborates with the researchers at the Gdansk Medical University (Poland), Rīga Stradiņš University (Latvia), University of Tartu (Estonia), Universities of Montpellier and of Lille (France), University of Veterinary and Pharmaceutical Sciences of Brno (the Czech Republic), University of Cagliari (Italy), UAB Dermedika.